Skip to main content
. 2018 Jun;10(6):3849–3868. doi: 10.21037/jtd.2018.05.204

Table 1. Available treatment options in community acquired respiratory virus infections.

Virus Available treatment
Influenza Neuraminidase inhibitors: Oseltamivir (oral);
Zanamivir (nasal, intravenous)
Parainfluenza Ribavirin (nebulised, intravenous)
Respiratory syncytial virus Ribavirin (nebulised, intravenous)
Human metapneumovirus Ribavirin (nebulised, intravenous)
Human rhinovirus Supportive treatment
Adenovirus Supportive treatment
Coronavirus Supportive treatment
Bocavirus Supportive treatment